ARCA biopharma Inc. is a clinical stage biopharmaceutical company focused on developing genetically targeted therapies for cardiovascular diseases. With a focus on precision medicine, ARCA aims to revolutionize treatment options for patients suffering from genetic cardiovascular conditions.
